A citation-based method for searching scientific literature

Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Hiroshi Ikegami. J Diabetes Investig 2020
Times Cited: 5







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
734
100

Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes.
Xingran Cui, Amir Abduljalil, Brad D Manor, Chung-Kang Peng, Vera Novak. PLoS One 2014
46
40

Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients.
Carlos E Mendez, Ki-Tae Mok, Ashar Ata, Robert J Tanenberg, Jorge Calles-Escandon, Guillermo E Umpierrez. Diabetes Care 2013
116
40


Capillary and venous blood glucose concentrations measured during intravenous insulin and glucose infusion: a comparison of steady and dynamic states.
Kirsten Kempe, David Price, John Ellison, Joseph Marhoul, Linda Morrow, Khin Win, Kirstin Kuschma, Marcus Hompesch. Diabetes Technol Ther 2009
13
40

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
Denice S Feig, Lois E Donovan, Rosa Corcoy, Kellie E Murphy, Stephanie A Amiel, Katharine F Hunt, Elizabeth Asztalos, Jon F R Barrett, J Johanna Sanchez, Alberto de Leiva,[...]. Lancet 2017
217
40

Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
Andrea Tumminia, Salvatore Crimi, Laura Sciacca, Massimo Buscema, Lucia Frittitta, Sebastiano Squatrito, Riccardo Vigneri, Letizia Tomaselli. Diabetes Metab Res Rev 2015
40
40

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
406
40

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
668
40

The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
Anna L Secher, Lene Ringholm, Henrik U Andersen, Peter Damm, Elisabeth R Mathiesen. Diabetes Care 2013
110
40


Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium-glucose cotransporter 2 inhibitor: A randomized, open-label, prospective study.
Ken Kanazawa, Hiroshi Uchino, Fumika Shigiyama, Hiroyuki Igarashi, Kayoko Ikehara, Fukumi Yoshikawa, Shuki Usui, Masahiko Miyagi, Hiroshi Yoshino, Yasuyo Ando,[...]. J Diabetes Investig 2019
1
100


Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
20

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.
Ele Ferrannini, Anna Solini. Nat Rev Endocrinol 2012
260
20

Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
Robert R Henry, Julio Rosenstock, Steven Edelman, Sunder Mudaliar, Alexandros-Georgios Chalamandaris, Sreeneeranj Kasichayanula, Allyson Bogle, Nayyar Iqbal, James List, Steven C Griffen. Diabetes Care 2015
151
20

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4-week, double-blind, randomized, placebo-controlled phase 2 trial.
Akira Shimada, Toshiaki Hanafusa, Atsutaka Yasui, Ganghyuck Lee, Yusuke Taneda, Akiko Sarashina, Kosuke Shiki, Jyothis George, Nima Soleymanlou, Jan Marquard. Diabetes Obes Metab 2018
21
20

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
358
20

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
156
20


The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.
Jiao Chen, Fang Fan, J Y Wang, Yang Long, C L Gao, R C Stanton, Yong Xu. Sci Rep 2017
47
20

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
20


Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Arthur T Sands, Brian P Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W Bode, Satish K Garg, John B Buse, Phillip Banks, Rubina Heptulla, Marc Rendell,[...]. Diabetes Care 2015
125
20


Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
203
20

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2.
Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, Fredrik Thorén, John Xu, Anna Maria Langkilde. Diabetes Care 2019
26
20

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
48
20

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.
Thomas Danne, Satish Garg, Anne L Peters, John B Buse, Chantal Mathieu, Jeremy H Pettus, Charles M Alexander, Tadej Battelino, F Javier Ampudia-Blasco, Bruce W Bode,[...]. Diabetes Care 2019
112
20

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.
Roy W Beck, Bruce Buckingham, Kellee Miller, Howard Wolpert, Dongyuan Xing, Jennifer M Block, H Peter Chase, Irl Hirsch, Craig Kollman, Lori Laffel,[...]. Diabetes Care 2009
179
20


Effectiveness of Internet-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials.
Ying Shen, Fengbin Wang, Xing Zhang, Xiaorou Zhu, Qiudan Sun, Edwin Fisher, Xinying Sun. J Med Internet Res 2018
14
20

Continuous glucose monitoring pilot in low-income type 1 diabetes patients.
Paola A Sequeira, Lucy Montoya, Valerie Ruelas, Dongyuan Xing, Vincent Chen, Roy Beck, Anne L Peters. Diabetes Technol Ther 2013
19
20

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic.
Rodolfo J Galindo, Grazia Aleppo, David C Klonoff, Elias K Spanakis, Shivani Agarwal, Priya Vellanki, Darin E Olson, Guillermo E Umpierrez, Georgia M Davis, Francisco J Pasquel. J Diabetes Sci Technol 2020
40
20

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Beate Karges, Anke Schwandt, Bettina Heidtmann, Olga Kordonouri, Elisabeth Binder, Ulrike Schierloh, Claudia Boettcher, Thomas Kapellen, Joachim Rosenbauer, Reinhard W Holl. JAMA 2017
146
20

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
Marco Castellana, Claudia Parisi, Sergio Di Molfetta, Ludovico Di Gioia, Annalisa Natalicchio, Sebastio Perrini, Angelo Cignarelli, Luigi Laviola, Francesco Giorgino. BMJ Open Diabetes Res Care 2020
10
20

A comparison of dosing accuracy: visually impaired and sighted people using insulin pens.
Ann S Williams, Patrick A Schnarrenberger. J Diabetes Sci Technol 2010
12
20


Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature.
Stefan Pleus, Sina Ulbrich, Eva Zschornack, Stefanie Kamann, Cornelia Haug, Guido Freckmann. Diabetes Technol Ther 2019
17
20

Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
Marine Halbron, Olivier Bourron, Fabrizio Andreelli, Cecile Ciangura, Sophie Jacqueminet, Marc Popelier, Frederic Bosquet, Stephanie Rouanet, Chloe Amouyal, Agnes Hartemann. Diabetes Technol Ther 2019
7
20

The implanted glucose monitoring system Eversense: An alternative for diabetes patients with isobornyl acrylate allergy.
Eva Oppel, Stefanie Kamann, Lutz Heinemann, Franz-Xaver Reichl, Christof Högg. Contact Dermatitis 2020
8
20

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.
Richard M Bergenstal, Mary Johnson, Rebecca Passi, Anuj Bhargava, Natalie Young, Davida F Kruger, Eran Bashan, Stanley G Bisgaier, Deanna J Marriott Isaman, Israel Hodish. Lancet 2019
19
20

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
191
20

Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
Susana R Patton, Amy E Noser, Erin M Youngkin, Shideh Majidi, Mark A Clements. Diabetes Technol Ther 2019
12
20



Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor.
Anne Herman, Olivier Aerts, Marie Baeck, Magnus Bruze, Christophe De Block, An Goossens, Nils Hamnerius, Sara Huygens, Dominique Maiter, Dominique Tennstedt,[...]. Contact Dermatitis 2017
105
20

The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age.
Laura M Gandrud, Dongyuan Xing, Craig Kollman, Jen M Block, Betsy Kunselman, Darrell M Wilson, Bruce A Buckingham. Diabetes Technol Ther 2007
43
20

Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
Olga Kordonouri, Reinhard Hartmann, Kerstin Remus, Sarah Bläsig, Evelin Sadeghian, Thomas Danne. Pediatr Diabetes 2012
55
20

History and Perspective on DIY Closed Looping.
Dana Lewis. J Diabetes Sci Technol 2019
48
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.